Paper8777280
Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.
Linn T and 3 others. Acta Diabetol, 1996. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice. Papers, record 8777280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8777280
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glucagon-like-peptide-1 (7-36) amide improves glucose sensitivity in beta-cells of NOD mice.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Glucose | Major topic |
| Insulin | Major topic |
| Islets of Langerhans | Major topic |
| Peptide Fragments | Major topic |
| Animals | |
| Cells, Cultured | |
| Glucagon | |
| Glucagon-Like Peptide 1 | |
| Glucagon-Like Peptides | |
| In Vitro Techniques | |
| Insulin Secretion | |
| Kinetics | |
| Mice | |
| Mice, Inbred NOD | |
| Mice, Mutant Strains | |
| Pancreas | |
| Time Factors |
Source PubMed
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8516568 | Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas. | Res Exp Med (Berl) | 1993 | https://conductscience.org/library/papers/8516568 | PubMed |
| 2 | 8423228 | Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. | J Clin Invest | 1993 | https://conductscience.org/library/papers/8423228 | PubMed |
| 3 | 8446036 | Glucagon-like peptide-I-(7-37) suppresses hyperglycemia in rats. | Metabolism | 1993 | https://conductscience.org/library/papers/8446036 | PubMed |
| 4 | 3264405 | Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/3264405 | PubMed |
| 5 | 7517895 | Signal transduction of the GLP-1-receptor cloned from a human insulinoma. | FEBS Lett | 1994 | https://conductscience.org/library/papers/7517895 | PubMed |
| 6 | 1348845 | Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1348845 | PubMed |
| 7 | 8381211 | Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). | Nature | 1993 | https://conductscience.org/library/papers/8381211 | PubMed |
| 8 | 8405712 | Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor. | Diabetes | 1993 | https://conductscience.org/library/papers/8405712 | PubMed |
| 9 | 2171911 | Interleukin-1 beta depletes insulin messenger ribonucleic acid and increases the heat shock protein hsp70 in mouse pancreatic islets without impairing the glucose metabolism. | Endocrinology | 1990 | https://conductscience.org/library/papers/2171911 | PubMed |
| 10 | 3902545 | New developments in the incretin concept. | Diabetologia | 1985 | https://conductscience.org/library/papers/3902545 | PubMed |
| 11 | 7905842 | International Symposium on Glucagon-Like Peptide-1. Copenhagen, Denmark, May 17-19, 1993. Abstracts. | Digestion | 1993 | https://conductscience.org/library/papers/7905842 | PubMed |
| 12 | 1705823 | Priming effect of glucagon-like peptide-1 (7-36) amide, glucose-dependent insulinotropic polypeptide and cholecystokinin-8 at the isolated perfused rat pancreas. | Biochim Biophys Acta | 1991 | https://conductscience.org/library/papers/1705823 | PubMed |
| 13 | 2245873 | Elusive proximal signals of beta-cells for insulin secretion. | Diabetes | 1990 | https://conductscience.org/library/papers/2245873 | PubMed |
| 14 | 1647951 | Glucagon-like peptide-1(7-36) amide is a new incretin/enterogastrone candidate. | Eur J Clin Invest | 1991 | https://conductscience.org/library/papers/1647951 | PubMed |
| 15 | 1565148 | The enteroinsular axis revisited. A novel role for an incretin. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1565148 | PubMed |
| 16 | 8036284 | The insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-37) in normal and diabetic subjects. | Regul Pept | 1994 | https://conductscience.org/library/papers/8036284 | PubMed |
| 17 | 8112494 | Detection of the human glucagon-like peptide 1(7-36) amide receptor on insulinoma-derived cell membranes. | Digestion | 1994 | https://conductscience.org/library/papers/8112494 | PubMed |
| 18 | 8307251 | Spontaneous glucose intolerance in the progeny of low dose streptozotocin-induced diabetic mice. | Diabetologia | 1993 | https://conductscience.org/library/papers/8307251 | PubMed |
| 19 | 2645190 | Glucagonlike peptide I (7-37) actions on endocrine pancreas. | Diabetes | 1989 | https://conductscience.org/library/papers/2645190 | PubMed |
| 20 | 2564338 | Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases. | Endocrinology | 1989 | https://conductscience.org/library/papers/2564338 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41984373 | Glucagon-Like Peptide-1 Receptor Agonists: Their Potential Role in Prediabetes. | Diabetes Ther | 2026 | https://conductscience.org/library/papers/41984373 | PubMed |
| 39101164 | Effects of dulaglutide and trelagliptin on beta-cell function in patients with type 2 diabetes: a randomized controlled study: DUET-beta study. | Diabetol Int | 2024 | https://conductscience.org/library/papers/39101164 | PubMed |
| 35273901 | Repurposing of existing antibiotics for the treatment of diabetes mellitus. | In Silico Pharmacol | 2022 | https://conductscience.org/library/papers/35273901 | PubMed |
| 28270518 | Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist. | FASEB J | 2017 | https://conductscience.org/library/papers/28270518 | PubMed |
| 27212208 | Novel application of hydrophobin in medical science: a drug carrier for improving serum stability. | Sci Rep | 2016 | https://conductscience.org/library/papers/27212208 | PubMed |
| 20491795 | The Type 1 Diabetes PhysioLab Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse. | Clin Exp Immunol | 2010 | https://conductscience.org/library/papers/20491795 | PubMed |
| 18063685 | Exendin-4 modulates diabetes onset in nonobese diabetic mice. | Endocrinology | 2008 | https://conductscience.org/library/papers/18063685 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8777280
GET https://conductscience.org/api/papers/v1/8777280/references?page=2